Bright fluorescent Streptococcus pneumoniae for live-cell imaging of host-pathogen interactions

Journal of Bacteriology

Volumn 197, Issue 5, 2015, Pages 807-818

  Kjos, Morten ^a   Aprianto, Rieza ^a   Fernandes, Vitor E ^b   Andrew, Peter W ^b   Van Strijp, Jos A G ^c   Nijland, Reindert ^c,d   Veening, Jan Willem ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HISTONE; HISTONE H1PA; POLYSACCHARIDE; RED FLUORESCENT PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL PROTEIN;

ANIMAL TISSUE; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL ENCAPSULATION; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; ANIMAL; CELL TRACKING; CHEMISTRY; EVALUATION STUDY; FEMALE; FLUORESCENCE; GENETICS; LUNG; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PNEUMOCOCCAL INFECTION; PROCEDURES; REPORTER GENE;

STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTERIAL PROTEINS; CELL TRACKING; FEMALE; FLUORESCENCE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG; MICE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VIRULENCE FACTORS;

EID: 84961292197     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.02221-14     Document Type: Article

References (57)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893-902. http://dx.doi.org/10.1016/S0140 -6736(09)61204-6.
2. Griffith F. 1928. The significance of pneumococcal types. J Hyg (Lond) 27:113-159. http://dx.doi.org/10.1017/S0022172400031879.
3. Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS. 2010. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun 78:704-715. http://dx.doi.org/10.1128/IAI.00881-09.
4. Abeyta M, Hardy GG, Yother J. 2003. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect Immun 71:218-225. http://dx.doi.org/10.1128/IAI.71.1.218-225.2003.
5. Kim JO, Romero-Steiner S, Sørensen UB, Blom J, Carvalho M, Barnard S, Carlone G, Weiser JN. 1999. Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae. Infect Immun 67:2327-2333.
6. Weinberger DM, Trzciński K, Lu Y-J, Bogaert D, Brandes A, Galagan J, Anderson PW, Malley R, Lipsitch M. 2009. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 5:e1000476. http://dx.doi.org/10.1371/journal.ppat.1000476.
7. Henriques-Normark B, Tuomanen EI. 2013. The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb Perspect Med 3:a010215. http://dx.doi.org/10.1101/cshperspect.a010215.
8. Weiser JN, Austrian R, Sreenivasan PK, Masure HR. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 62:2582-2589.
9. Chewapreecha C, Harris SR, Croucher NJ, Turner C, Marttinen P, Cheng L, Pessia A, Aanensen DM, Mather AE, Page AJ, Salter SJ, Harris D, Nosten F, Goldblatt D, Corander J, Parkhill J, Turner P, Bentley SD. 2014. Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet 46:305-309. http://dx.doi.org/10.1038/ng.2895.
10. Zhang Z, Clarke TB, Weiser JN. 2009. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119:1899-1909. http://dx.doi.org/10.1172/JCI36731.
11. Sanchez CJ, Shivshankar P, Stol K, Trakhtenbroit S, Sullam PM, Sauer K, Hermans PWM, Orihuela CJ. 2010. The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog 6:e1001044. http://dx .doi.org/10.1371/journal.ppat.1001044.
12. Parker D, Soong G, Planet P, Brower J, Ratner AJ, Prince A. 2009. The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun 77:3722-3730. http://dx.doi.org/10.1128/IAI .00228-09.
13. Elhaik-Goldman S, Kafka D, Yossef R, Hadad U, Elkabets M, Vallon- Eberhard A, Hulihel L, Jung S, Ghadially H, Braiman A, Apte RN, Mandelboim O, Dagan R, Mizrachi-Nebenzahl Y, Porgador A. 2011. The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk. PLoS One 6:e23472. http://dx.doi.org/10.1371/journal.pone.0023472.
14. Srivastava A, Casey H, Johnson N, Levy O, Malley R. 2007. Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease. Infect Immun 75:342-349. http://dx.doi.org/10 .1128/IAI.01089-06.
15. Colino J, Shen Y, Snapper CM. 2002. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms. J Exp Med 195:1-14. http://dx.doi.org/10.1084/jem.20011432.
16. Mook-Kanamori BB, Rouse MS, Kang C-I, van de Beek D, Steckelberg JM, Patel R. 2009. Daptomycin in experimental murine pneumococcal meningitis. BMC Infect Dis 9:50. http://dx.doi.org/10.1186 /1471-2334-9-50.
17. Francis KP, Yu J, Bellinger-Kawahara C, Joh D, Hawkinson MJ, Xiao G, Purchio TF, Caparon MG, Lipsitch M, Contag PR. 2001. Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel Gram-positive lux transposon. Infect Immun 69:3350-3358. http://dx.doi.org/10.1128/IAI .69.5.3350-3358.2001.
18. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI. 2004. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190:1661-1669. http://dx.doi.org/10.1086/424596.
19. Wang J, Barke RA, Charboneau R, Schwendener R, Roy S. 2008. Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-κ B signaling. J Immunol 180:3594-3600. http://dx.doi.org/10.4049/jimmunol.180.5.3594.
20. Johnson AW, Sidman JD, Lin J. 2013. Bioluminescent imaging of pneumococcal otitis media in chinchillas. Ann Otol Rhinol Laryngol 122:344-352. http://dx.doi.org/10.1177/000348941312200510.
21. Kadioglu A, Sharpe JA, Lazou I, Svanborg C, Ockleford C, Mitchell TJ, Andrew PW. 2001. Use of green fluorescent protein in visualisation of pneumococcal invasion of broncho-epithelial cells in vivo. FEMS Microbiol Lett 194:105-110. http://dx.doi.org/10.1111/j.1574 -6968.2001.tb09454.x.
22. Ribes S, Ebert S, Regen T, Agarwal A, Tauber SC, Czesnik D, Spreer A, Bunkowski S, Eiffert H, Hanisch U-K, Hammerschmidt S, Nau R. 2010. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun 78:865-871. http://dx.doi.org/10.1128 /IAI.01110-09.
23. Martin B, Garcia P, Castanié M-P, Claverys J-P. 1995. The recA gene of Streptococcus pneumoniae is part of a competence-induced operon and controls lysogenic induction. Mol Microbiol 15:367-379. http://dx.doi .org/10.1111/j.1365-2958.1995.tb02250.x.
24. Sorg RA, Kuipers OP, Veening J-W. Gene expression platform for synthetic biology in the human pathogen Streptococcus pneumoniae. ACS Synth Biol, in press. http://dx.doi.org/10.1021/sb500229s.
25. Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T. 2001. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng 14:529-532. http://dx.doi.org/10.1093/protein/14.8 .529.
26. Yuzenkova Y, Gamba P, Herber M, Attaiech L, Shafeeq S, Kuipers OP, Klumpp S, Zenkin N, Veening J-W. 2014. Control of transcription elongation by GreA determines rate of gene expression in Streptococcus pneumoniae. Nucleic Acids Res 42:10987-10999. http://dx.doi.org/10 .1093/nar/gku790.
27. Overkamp W, Beilharz K, Detert Oude Weme R, Solopova A, Karsens H, Kovácsá T, Kok J, Kuipers OP, Veening J-W. 2013. Benchmarking various green fluorescent protein variants in Bacillus subtilis, Streptococcus pneumoniae, and Lactococcus lactis for live cell imaging. Appl Environ Microbiol 79:6481-6490. http://dx.doi.org/10.1128/AEM.02033-13.
28. Kjos M, Veening J-W. 2014. Tracking of chromosome dynamics in live Streptococcus pneumoniae reveals that transcription promotes chromosome segregation. Mol Microbiol 91:1088-1105. http://dx.doi.org/10 .1111/mmi.12517.
29. Ramos-Montañez S, Kazmierczak KM, Hentchel KL, Winkler ME. 2010. Instability of ackA (acetate kinase) mutations and their effects on acetyl phosphate and ATP amounts in Streptococcus pneumoniae D39. J Bacteriol 192:6390-6400. http://dx.doi.org/10.1128/JB.00995-10.
30. Jørgensen MG, van Raaphorst R, Veening J-W. 2013. Noise and stochasticity in gene expression: a pathogenic fate determinant, p 157-176. In Harwood C, Wipat A (ed), Microbial synthetic biology Academic Press, Oxford, United Kingdom.
31. De Jong IG, Beilharz K, Kuipers OP, Veening J-W. 2011. Live cell imaging of Bacillus subtilis and Streptococcus pneumoniae using automated time-lapse microscopy. J Vis Exp 53:3145. http://dx.doi.org/10 .3791/3145.
32. Shoemaker NB, Guild WR. 1972. Kinetics of integration of transforming DNAin pneumococcus. Proc Natl Acad SciUSA69:3331-3335. http://dx .doi.org/10.1073/pnas.69.11.3331.
33. Morton DB, Griffiths PH. 1985. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Rec 116:431-436. http://dx.doi.org/10.1136/vr.116.16 .431.
34. Kadioglu A, Gingles NA, Grattan K, Kerr A, Mitchell TJ, Andrew PW. 2000. Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 68:492-501. http://dx.doi.org/10.1128/IAI.68.2.492 -501.2000.
35. Mlacha SZK, Romero-Steiner S, Hotopp JCD, Kumar N, Ishmael N, Riley DR, Farooq U, Creasy TH, Tallon LJ, Liu X, Goldsmith CS, Sampson J, Carlone GM, Hollingshead SK, Scott JAG, Tettelin H. 2013. Phenotypic, genomic, and transcriptional characterization of Streptococcus pneumoniae interacting with human pharyngeal cells. BMC Genomics 14:383. http://dx.doi.org/10.1186/1471-2164-14-383.
36. Surewaard BGJ, van Strijp JAG, Nijland R. 2013. Studying interactions of Staphylococcus aureus with neutrophils by flow cytometry and time lapse microscopy. J Vis Exp 77:e50788. http://dx.doi.org/10.3791/50788.
37. Yu J, Xiao J, Ren X, Lao K, Xie XS. 2006. Probing gene expression in live cells, one protein molecule at a time. Science 311:1600-1603. http://dx .doi.org/10.1126/science.1119623.
38. Davis RW, Timlin JA, Kaiser JN, Sinclair MB, Jones HDT, Lane TW. 2010. Accurate detection of low levels of fluorescence emission in autofluorescent background: Francisella-infected macrophage cells. Microsc Microanal 16:478-487. http://dx.doi.org/10.1017/S1431927610000322.
39. Liu D, Yumoto H, Murakami K, Hirota K, Ono T, Nagamune H, Kayama S, Matsuo T, Miyake Y. 2008. The essentiality and involvement of Streptococcus intermedius histone-like DNA-binding protein in bacterial viability and normal growth. Mol Microbiol 68:1268-1282. http://dx .doi.org/10.1111/j.1365-2958.2008.06232.x.
40. Slager J, Kjos M, Attaiech L, Veening J-W. 2014. Antibiotic-induced replication stress triggers bacterial competence by increasing gene dosage near the origin. Cell 157:395-406. http://dx.doi.org/10.1016/j.cell.2014.01.068.
41. Avery OT, Macleod CM, McCarty M. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 79:137-158. http://dx.doi.org/10 .1084/jem.79.2.137.
42. Nieto C, Espinosa M. 2003. Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein. Plasmid 49:281-285. http://dx.doi.org/10.1016 /S0147-619X(03)00020-9.
43. Cormack BP, Valdivia RH, Falkow S. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38. http://dx.doi.org /10.1016/0378-1119(95)00685-0.
44. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN. 2007. Capsule enhances pneumococcal colonization by limiting mucusmediated clearance. Infect Immun 75:83-90. http://dx.doi.org/10.1128 /IAI.01475-06.
45. Kadioglu A, Weiser JN, Paton JC, Andrew PW. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6:288-301. http://dx.doi.org/10.1038 /nrmicro1871.
46. Weiser JN. 2010. The pneumococcus: why a commensal misbehaves. J Mol Med 88:97-102. http://dx.doi.org/10.1007/s00109-009-0557-x.
47. Cartee RT, Forsee WT, Bender MH, Ambrose KD, Yother J. 2005. CpsE from type 2 Streptococcus pneumoniae catalyzes the reversible addition of glucose-1-phosphate to a polyprenyl phosphate acceptor, initiating type 2 capsule repeat unit formation. J Bacteriol 187:7425-7433. http://dx.doi .org/10.1128/JB.187.21.7425-7433.2005.
48. Talbot UM, Paton AW, Paton JC. 1996. Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect Immun 64:3772-3777.
49. Berry AM, Paton JC. 1996. Sequence heterogeneity of PsaA, a 37- kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect Immun 64:5255-5262.
50. Pracht D, Elm C, Gerber J, Bergmann S, Rohde M, Seiler M, Kim KS, Jenkinson HF, Nau R, Hammerschmidt S. 2005. PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation. Infect Immun 73:2680-2689. http://dx.doi.org/10.1128/IAI.73.5 .2680-2689.2005.
51. Hammerschmidt S, Agarwal V, Kunert A, Haelbich S, Skerka C, Zipfel PF. 2007. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J Immunol 178:5848-5858. http://dx.doi .org/10.4049/jimmunol.178.9.5848.
52. Hammerschmidt S, Wolff S, Hocke A, Rosseau S, Müller E, Rohde M. 2005. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun 73:4653-4667. http: //dx.doi.org/10.1128/IAI.73.8.4653-4667.2005.
53. Wartha F, Beiter K, Albiger B, Fernebro J, Zychlinsky A, Normark S, Henriques-Normark B. 2007. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol 9:1162-1171. http://dx.doi.org/10.1111/j.1462-5822.2006 .00857.x.
54. Manso AS, Chai MH, Atack JM, Furi L, De Ste Croix M, Haigh R, Trappetti C, Ogunniyi AD, Shewell LK, Boitano M, Clark TA, Korlach J, Blades M, Mirkes E, Gorban AN, Paton JC, Jennings MP, Oggioni MR. 2014. A random six-phase switch regulates pneumococcal virulence via global epigenetic changes. Nat Commun 5:5055. http://dx.doi.org/10 .1038/ncomms6055.
55. Shainheit MG, Mulé M, Camilli A. 2014. The core promoter of the capsule operon of Streptococcus pneumoniae is necessary for colonization and invasive disease. Infect Immun 82:694-705. http://dx.doi.org/10 .1128/IAI.01289-13.
56. Geno KA, Hauser JR, Gupta K, Yother J. 2014. Streptococcus pneumoniae phosphotyrosine phosphatase CpsB and alterations in capsule production resulting from changes in oxygen availability. J Bacteriol 196:1992-2003. http://dx.doi.org/10.1128/JB.01545-14.
57. Yother J. 2011. Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu Rev Microbiol 65:563-581. http://dx.doi.org/10.1146/annurev.micro.62.081307 .162944.